Loading clinical trials...
Loading clinical trials...
Ondansetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of ondansetron. The investigators therefore will perf...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Seoul National University Bundang Hospital
NCT06403163 · Transfusion Reaction, Transfusion Related Complication, and more
NCT00178594 · Blood Coagulation Disorders, Inherited, Thrombotic Disorder
NCT02601053 · Blood Coagulation Disorder
NCT03734588 · Adeno-Associated Virus (AAV), Blood Coagulation Disorder, and more
NCT05064267 · Kidney Disease, Chronic, Pediatric Kidney Disease, and more
Seoul National Univ. Bundang Hospital
Seongnam-si, Gyeonggi-do
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions